Advanced Solutions specializes in cutting-edge bioprinting technologies, particularly through their flagship product, the BioAssemblyBot (BAB). This advanced 3D bioprinter is designed to construct and assemble biological structures with high precision and efficiency. The BAB platform is UL and cGMP certified, ensuring compliance with safety and manufacturing standards. It is capable of producing a variety of biological constructs, including advanced 3D tissue models, organoids, and vascularized tissues, which are essential for applications in drug discovery, tissue engineering, and regenerative medicine. The system leverages over 60 years of industrial robotic innovation, making it a versatile tool for researchers and developers in the biomedical field.

In addition to the BioAssemblyBot, Advanced Solutions offers the Angiomics VIPM platform, which enables the creation of a functional human microcirculation in vitro. This technology utilizes human adipose microvessels to establish a vascularized tissue environment, facilitating advanced tissue modeling and therapeutic applications. The VIPM platform allows for the perfusion of bioprinted constructs and integrates seamlessly with other cellular components, creating a dynamic and adaptive microvascular network. This innovative approach not only enhances the fidelity of tissue models but also supports the development of complex tissue-vessel dynamics, paving the way for significant advancements in biomedical research and applications.

United States

For more than 30 years, Advanced Solutions, a privately held company, focused on long-term investments in technology companies that deliver profound and positive engineering solutions for healthcare, manufacturing, workflow optimization, logistics and education. 
Companies include: Advanced Solutions Life Sciences, Power of Public Speaking, Expedient, and IDS Engineering. 

Advanced Solutions Design Software and Advanced Solutions PLM are now part of IMAGINiT Technologies

Advanced Solutions

Company Details